MedicarePartD.guide

A non-government resource built from CMS public data

EDARBI 80 mg Tablet

Also known as Azilsartan Kamedoxomil. Coverage in Oregon and Washington (CMS PDP Region 30).

4 of 10 stand-alone Part D plans in Oregon and Washington cover this drug on tier 3–4.

2 of 4 plans apply a prior authorization, step therapy or quantity limit.

84 Medicare Advantage plans in OR, WA do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. OR: 31 plans · WA: 53 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Wellcare Value Script (PDP)$0.00/mo premium · $615.00 deductible3Preferred Brand25%25%$8.6787$26.043 units
  • Quantity limit 3 per 30 days
HealthSpring Assurance Rx (PDP)$0.00/mo premium · $615.00 deductible4Non-Preferred Drug30%30%$8.7775—None
HealthSpring Extra Rx (PDP)$50.00/mo premium · $615.00 deductible4Non-Preferred Drug30%30%$8.7833—None
AARP Medicare Rx Preferred from UHC (PDP)$110.00/mo premium · $130.00 deductible4Non-Preferred Drug37%—$9.5956$28.793 units
  • Quantity limit 3 per 30 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →